Citation: | GUO Changpeng, HU Xiaohua, CHENG Long, REN Zhiguo. Value of heparin-binding protein and interleukin-17A levels in bronchoalveolar lavage fluid in predicting prognosis of elderly patients with severe pneumonia[J]. Journal of Clinical Medicine in Practice, 2025, 29(3): 99-103. DOI: 10.7619/jcmp.20243049 |
To analyze the value of heparin-binding protein (HBP) and interleukin-17A (IL-17A) levels in bronchoalveolar lavage fluid in predicting prognosis of elderly patients with severe pneumonia.
A total of 105 elderly patients with severe pneumonia in the hospital from May 2022 to May 2024 were selected and divided into death group (n=32) and survival group (n=73) based on their survival outcomes within 28 days after admission. The levels of HBP and IL-17A in bronchoalveolar lavage fluid were compared between the two groups; the Logistic regression analysis was conducted to explore the influencing factors for prognosis in elderly patients with severe pneumonia; the receiver operating characteristic (ROC) curve was plotted to analyze the predictive efficiencies of HBP and IL-17A in bronchoalveolar lavage fluid for the prognosis of elderly patients with severe pneumonia.
The levels of HBP and IL-17A in bronchoalveolar lavage fluid in the death group were significantly higher than those in the survival group (P < 0.01). There were significant differences in the Acute Physiology and Chronic Health Evaluation Ⅱ (APACHE Ⅱ) score and blood lactate (Lac) level between the two groups (P < 0.01). Logistic regression analysis showed that HBP (OR=3.084, 95%CI, 1.326 to 4.694), IL-17A (OR=4.521, 95%CI, 2.164 to 7.841), APACHE Ⅱ score (OR=2.039, 95%CI, 1.069 to 2.859), and Lac (OR=2.627, 95%CI, 1.168 to 3.058) were influencing factors for the prognosis of elderly patients with severe pneumonia (P < 0.05). When the optimal cut-off values were set at 15.92 ng/mL for HBP and 109.34 pg/mL for IL-17A, the area under the curve (AUC) for the combined prediction of prognosis by HBP and IL-17A in bronchoalveolar lavage fluid was 0.852, with a 95%CI of 0.801 to 0.948. The AUC for the combined prediction of prognosis by HBP and IL-17A in bronchoalveolar lavage fluid was significantly higher than that for single tests (Z=2.906, 2.416, P=0.007, 0.014).
Increased levels of HBP and IL-17A in bronchoalveolar lavage fluid, decreased APACHE Ⅱ score, and increased Lac are influencing factors for the prognosis of elderly patients with severe pneumonia. Combined detection of HBP and IL-17A in bronchoalveolar lavage fluid has high sensitivity in predicting the prognosis of elderly patients with severe pneumonia.
[1] |
徐诚之, 刘云, 殷菲. 床旁超声对重症肺炎患者病情严重程度及预后的评估价值[J]. 实用临床医药杂志, 2022, 26(22): 38-42.
|
[2] |
李丽, 何正光, 赵勇, 等. 血清中性粒细胞/淋巴细胞比值、可溶性髓系细胞触发受体1、降钙素原预测老年重症肺炎死亡风险的价值[J]. 安徽医药, 2021, 25(12): 2431-2435.
|
[3] |
商焕霞, 倪为波, 席素雅, 等. 血清FOXM1和PD-L1在老年重症肺炎早期诊断及预后评估中的预测价值[J]. 临床和实验医学杂志, 2023, 22(24): 2608-2612.
|
[4] |
郭昌鹏, 王光艳, 耿岩, 等. 血清肝素结合蛋白联合可溶性髓样细胞触发受体1对慢性阻塞性肺疾病急性加重患者细菌感染的诊断效果[J]. 中国医刊, 2021, 56(7): 724-728.
|
[5] |
庄兰妹, 陈海华, 朱婷, 等. 慢性阻塞性肺疾病急性期血清白细胞介素-6、白细胞介素-13和白细胞介素-17A水平与GOLD分级的关系[J]. 安徽医药, 2022, 26(4): 750-754.
|
[6] |
中国医师协会急诊医师分会. 中国急诊重症肺炎临床实践专家共识[J]. 中国急救医学, 2016, 36(2): 97-107.
|
[7] |
杨依磊, 张虎, 曹佳, 等. 多黏菌素B雾化吸入在机械通气重症肺炎患者中的有效性和安全性[J]. 中国药房, 2023, 34(19): 2385-2390.
|
[8] |
哈宗兰, 马丽娜, 马琼, 等. miR-146a、miR-127对老年重症肺炎患者临床风险和预后的预测价值[J]. 中国急救复苏与灾害医学杂志, 2022, 17(9): 1194-1197.
|
[9] |
陈永生, 付斌, 郑永先, 等. 血清活化蛋白C及内皮素1和血管细胞黏附分子-1对老年重症肺炎合并呼吸衰竭患者病情进展及预后评估的价值[J]. 临床急诊杂志, 2022, 23(7): 494-497, 509.
|
[10] |
李祥, 张超, 李庆睿, 等. 血清乳酸、可溶性髓样细胞触发受体-1、降钙素原水平变化与老年重症肺炎患者急性生理慢性健康评分的相关性及临床意义[J]. 中国临床保健杂志, 2023, 26(1): 105-108.
|
[11] |
王一律, 王真, 钟文, 等. PCT和hs-CRP联合临床肺部感染评分对老年重症肺炎患者预后评估的价值[J]. 河北医学, 2023, 29(2): 289-293.
|
[12] |
范江花, 罗海燕, 张新萍, 等. 肝素结合蛋白在重症腺病毒肺炎中的应用[J]. 中华实用儿科临床杂志, 2021, 36(18): 1389-1393.
|
[13] |
雷颖, 宋水江, 汪涛, 等. HBP、IGF、PCT水平在脑梗死并发医院获得性肺炎诊断和病情评价中的价值[J]. 中华医院感染学杂志, 2022, 32(18): 2777-2780.
|
[14] |
郭磊, 张铮, 沈华, 等. 肝素结合蛋白对呼吸道病毒感染的诊断及预后评估价值[J]. 中华急诊医学杂志, 2021, 30(12): 1465-1469.
|
[15] |
刘维鹏, 朱青山, 冯连杰, 等. 中性粒细胞与淋巴细胞比值、白细胞介素-17A及转化生长因子-β对局部晚期非小细胞肺癌患者发生放射性肺炎的诊断价值[J]. 癌症进展, 2022, 20(3): 282-285.
|
[16] |
闫静, 侯艳苗, 王振华. 难治性支原体肺炎患儿血清LncRNA NNT-AS1、IL-17A水平变化及临床意义[J]. 中华全科医学, 2024, 22(3): 447-450, 468.
|
[17] |
周斌, 万少兵, 王瑛, 等. JAK2/STAT3信号通路调控急性肺损伤过程中Th17/Treg失衡机制的研究[J]. 中国比较医学杂志, 2023, 33(6): 75-80.
|
[18] |
HOUSE E L, KIM S Y, CHALUPA D, et al. IL-17A neutralization fails to attenuate airway remodeling and potentiates a proinflammatory lung microenvironment in diacetyl-exposed rats[J]. Am J Physiol Lung Cell Mol Physiol, 2023, 325(4): L434-L446.
|
[19] |
黄秀红, 肖凌云, 翟素平. MCP-1、sICAM-1、RAGE、sTREM-1血清水平变化与重症肺炎APACHEII评分的关联性分析[J]. 实验与检验医学, 2021, 39(3): 691-693.
|
[20] |
陈秀琴, 黄玉麟, 汤俊. 重症肺炎患者血小板参数、OI值与患者治疗结局关系的多因素分析[J]. 临床和实验医学杂志, 2021, 20(11): 1195-1198.
|
[21] |
孙静静, 王长强, 冉宇. 老年重症肺炎合并脓毒性休克病人预后影响因素分析[J]. 实用老年医学, 2020, 34(5): 439-442.
|
[22] |
毕惠娟, 沈继录, 方文浩, 等. 肺泡灌洗液肝素结合蛋白在细菌性肺炎诊断与鉴别诊断中的临床价值[J]. 中华临床感染病杂志, 2021, 14(2): 116-120.
|